Simon F. Lerner

Buenos Aires, C, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Experimental glaucoma triggers a pro-oxidative and pro-inflammatory state in the rat cornea.

Experimental glaucoma triggers a pro-oxidative and pro-inflammatory state in the rat cornea.

Journal: Biochimica et biophysica acta. General subjects

Published: April 10, 2023

Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model.

Mitochondrial function is impaired in the primary visual cortex in an experimental glaucoma model.

Journal: Archives of biochemistry and biophysics

Published: November 24, 2020

The World Glaucoma Association During the COVID-19 Pandemic.

The World Glaucoma Association During the COVID-19 Pandemic.

Journal: Journal of glaucoma

Published: May 28, 2020

Glaucoma causes redox imbalance in the primary visual cortex by modulating NADPH oxidase-4, iNOS, and Nrf2 pathway in a rat experimental model.

Glaucoma causes redox imbalance in the primary visual cortex by modulating NADPH oxidase-4, iNOS, and Nrf2 pathway in a rat experimental model.

Journal: Experimental eye research

Published: May 14, 2020

"White-puncture": A simple technique to prevent tearing of the anterior capsule during capsulorhexis in intumescent white cataracts.

"White-puncture": A simple technique to prevent tearing of the anterior capsule during capsulorhexis in intumescent white cataracts.

Journal: Archivos de la Sociedad Espanola de Oftalmologia

Published: May 11, 2020

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.

Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.

Journal: European journal of ophthalmology

Published: October 10, 2019

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension.

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: August 26, 2019

Glaucoma in the Age of E-Learning.

Glaucoma in the Age of E-Learning.

Journal: Journal of glaucoma

Published: April 12, 2019

Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci.

Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci.

Journal: Nature genetics

Published: September 30, 2016

Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy.

Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy.

Journal: Journal of ophthalmology

Published: September 21, 2016

RAND-like appropriateness methodology consensus for primary open-angle glaucoma in Latin America.

RAND-like appropriateness methodology consensus for primary open-angle glaucoma in Latin America.

Journal: American journal of ophthalmology

Published: November 22, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026